03:18 AM EDT, 09/09/2025 (MT Newswires) -- Frank McCormick, Director, on September 05, 2025, sold 74,000 shares in BridgeBio Pharma ( BBIO ) for $3,933,544. Following the Form 4 filing with the SEC, McCormick has control over a total of 963,254 common shares of the company, with 83,275 shares held directly and 879,979 controlled indirectly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1743881/000125780925000003/xslF345X05/wk-form4_1757369187.xml